2022
Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet Reactivity
Schneider D, Honda T, Feldmann E, de Havenon A, Romano J, Nogueira R, Prabhakaran S, Mishra N, Beaman C, Hinman J, Commichau C, Callas P, Kaneko N, Morales J, Patel S, Sharma L, Kim S, Taatjes‐Sommer H, Liebeskind D. Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet Reactivity. Stroke Vascular And Interventional Neurology 2022, 2 DOI: 10.1161/svin.121.000201.Peer-Reviewed Original ResearchStroke/transient ischemic attackTransient ischemic attackRecent myocardial infarctionMyocardial infarctionPlatelet expressionFcγRIIa expressionNeurologic dysfunctionPlatelet reactivitySubsequent stroke/transient ischemic attacksSubsequent cardiovascular eventsEmbolic causesNonembolic causesPlatelet FcγRIIACardiovascular eventsIschemic attackIdentifies patientsIschemic strokeMethods PatientsDischarge diagnosisTreatment decisionsLower riskPatientsPlatelet activationFlow cytometryEmbolic
2018
Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials
Zusterzeel R, Mishra NK, Beydoun H, Laschinger J, Wu C, Dong LM, Lin JA, Marinac-Dabic D, Strauss DG, Caños DA. Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials. Journal Of Women's Health 2018, 27: 808-814. PMID: 29741978, DOI: 10.1089/jwh.2017.6760.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementAortic valve replacementClinical trialsPatient-level dataPremarket clinical trialsLower riskMajor bleedingKidney injuryIschemic strokeValve replacementPacemaker implantationMortality riskDichotomous outcomesEfficacy of TAVRInvasive alternative approachPatient-Level MetaLong-term outcomesSex-specific outcomesLower mortality riskRandom-effects modelReintervention riskTAVR armIndividual comorbiditiesPostprocedural complicationsAcute outcomes